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This Month in the Journal
MC4-R Mutations and Autosomal Dominant Obesity,
by Sina et al. (pp. 1501–1507)
The melanocortin 4 receptor (MC4-R) is a G-protein–
coupled receptor, expressed in the hypothalamus, that
appears to mediate the hunger-suppressing effects of a-
melanocyte–stimulating hormone. Haploinsufficiency
for MCR4 has been seen in human families with extreme
obesity, a phenotype that is also found in heterozygous
animals carrying a targeted deletion of the mouse Mc4r.
Sina et al. have searched for mutations in this gene in a
group of 492 obese German children, and they report
here that 4 of their index patients, representing three
distinct families, harbor deletions or nonsense mutations
in this gene. The most extreme form of obesity is seen
primarily in women in these families, and, interestingly,
the knockout mice follow a similar pattern of pene-
trance. Since assortative mating for weight is well
known, it is not surprising that these families include
unrelated spouses who are themselves obese; as Sina et
al. note, this circumstance complicates efforts to estimate
the quantitative effect of MCR4 defects in these families.
The authors find that these families are relatively free of
diseases, such as diabetes and hypertension, that are typ-
ically associated with a high body-mass index. Although
the number of individuals in this group remains small,
this observation raises the possibility that this genetic
subtype of extreme obesity is relatively benign with re-
spect to co-morbid conditions.
Estimate of Hemophilia B Mutation Rates, by Green
et al. (pp. 1572–1579); and Sporadic and Detrimental
Mutation Rates, by Giannelli et al. (p. 1580–1587)
In this pair of papers, Giannelli and colleagues attempt
to estimate the rate of spontaneous mutations that occur
per human generation. First, they turn their attention to
the appearance of inactivating mutations in the factor
IX (FIX) gene, an X-linked locus that underlies the com-
mon bleeding disorder hemophilia B. For this work, the
authors take advantage of a nearly comprehensive col-
lection of British individuals and families with this dis-
ease, and they follow the emergence of all unique mu-
tations in the sample. In addition, they use family
histories and haplotype analysis to identify mutations
that arise independently within their group but that are
identical by state. These data allow them to estimate the
frequency of FIX mutations and to show that such mu-
tations arise more than eight times as often in the male
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germline than in the female germline. Their estimate of
the overall mutation rate in this gene agrees with pre-
vious estimates from smaller samples. However, contrary
to some earlier work that showed that males are par-
ticularly prone to mutations that involve a CrT tran-
sition at CpG dinucleotides, Gianelli et al. indicate that
different classes of mutations occur with the same rel-
ative frequency in the male and female germlines. In the
second paper, the authors pursue this theme of sex-spe-
cific mutation rates by examining the accumulated mu-
tations at several X- and Y-linked sites in a human male
versus those in a male chimpanzee. Despite the fact that
the X-linked loci had existed for two-thirds of their ev-
olutionary history in the female germline—whereas the
Y chromosome had been transmitted exclusively from
male to male—there was no evidence that these loci had
different patterns of mutations. Giannelli et al. estimate
that, on average, an individual carries 1100 novel mu-
tations, of which perhaps 1 may be expected to be
deleterious.
Telomeres of the Inactive X Chromosome, by Surralle´s
et al. (pp. 1617–1622)
The inactive X chromosome in a normal female cell can
be distinguished from its homologue by its later repli-
cation, its condensed, heterochromatic state, and its fail-
ure to stain with antibodies to acetylated histone. To this
list, Surralle´s and coworkers now add the instability of
its telomeres. Using a fluorescent probe specific to telo-
meric sequences, these authors performed quantitative
analysis on FISH images of metaphase cells taken from
females of different ages. When cells from newborns
were compared with those from women in their 30s or
their 60s, the overall telomeric fluorescence signal de-
creased in intensity, as a function of age—as would be
expected, given the steady shortening of telomeres at
each division in somatic cells. However, although telo-
meres on the active X chromosomes decreased in bright-
ness at a rate similar to what was seen in those on
autosomes, telomere fluorescence on the inactive X chro-
mosome declined significantly more rapidly. The basis
of this difference is unknown, but Surralle´s et al. suggest
that it accounts for the prevalence of X-monosomic cells
that have been found in the tissues of older women.
Chromosomal Linkage of Duane Retraction
Syndrome, by Appukuttan et al. (pp. 1639–1646)
Orientation of the gaze by the extraocular muscles is
significantly disrupted in Duane retraction syndrome
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(DRS), which owes its name to the tendency of the eye
to retract into its socket when an affected person at-
tempts to move the eye toward the medial position. On
the basis of both neuroanatomical evidence and recent
functional neuroimaging data, it appears that this defect
results from the absence of cranial nerve VI, the abdu-
cens nerve motor nucleus, which innervates the lateral
rectus muscle of the eye. Appukuttan et al. have iden-
tified a locus on 2q that is linked to a highly penetrant
dominant form of DRS. Working with an extended four-
generation family with this disorder, Appukuttan et al.
show that the underlying gene maps near an array of
homeobox genes, the HOXD cluster. These genes are
intriguing candidates for this condition, because they
encode transcription factors that regulate morphogenesis
and that are expressed in the brain. One other HOX
gene has been shown in knockout-mouse experiments
to affect one of the motor-neuron nuclei specifically.
However, Appukuttan and coworkers found no muta-
tions in the coding regions of the HOXD genes in their
study’s family with DRS.
Genetics of Ovarian Cancer in Women of Age !30
Years, by Stratton et al. (pp. 1725–1732)
Families with high incidence of breast cancer or hered-
itary nonpolyposis colorectal cancer are often found to
be subject to other cancers, including ovarian cancer. On
the basis of studies on such families, it has been proposed
that mutations in the BRCA1 and BRCA2 genes and in
two DNA-repair genes, hMSH2 and hMLH1, predispose
to early-onset ovarian cancer. Stratton and colleagues
observe that there is a dearth of information about the
risk of ovarian cancer for women in the general popu-
lation, but now they have analyzed DNA from a large
group of women who were diagnosed with early-onset
ovarian cancer. Crucially, these subjects, who had been
diagnosed over a period of 10 years in the United King-
dom, were ascertained without regard to a family histo-
ry of disease. None of the ∼100 individuals examined
carried identifiable mutations in BRCA1, BRCA2, or
hMSH2, although two carried mutations in hMLH1.
Moreover, no cases of early-onset ovarian cancer were
found among their first or second-degree relatives, and
no obvious familial clustering of ovarian cancer was
identified at any age. The lifetime risk for ovarian can-
cer—as well as for cancer overall—appears to be some-
what increased among relatives of these individuals, but
this modest increase in risk is in sharp contrast to that
calculated for close relatives of women with early-onset
breast cancer.
Heterogeneous Mitochondrial Point Mutations in
Deaf Families (letter to the editor), by Pandya et al.
(pp. 1803–1806)
Following up on their earlier finding of mitochondrial
mutations in Mongolian families with matrilineal deaf-
ness, Pandya et al. have screened a group of 480 deaf
people for two known sequence changes in their
mtDNA. Initial work with restriction enzymes identified
37 individuals with an Alw26I polymorphism, which
predicted that the well-known mutation 1555ArG was
involved in the condition, as well as 9 with an XbaI
polymorphism that has been seen in several families of
different ethnic backgrounds. This latter polymorphism
was expected to correspond to the previously identi-
fied 7445ArG substitution at the 3′ end of the cyto-
chrome oxidase I (COI) gene, but, in all 9 cases, the loss
of the XbaI site resulted from novel point mutations,
7443ArG, 7444ArG, or 7445ArC. The remarkable
concentration of distinct deafness mutations affecting
this short sequence probably does not identify a critical
region of the COI protein sequence, because 7445ArG
is a silent mutation that changes one stop codon to an-
other. Pandya et al. speculate that the nucleotide se-
quence that includes the XbaI site is required for normal
processing of the polycistronic RNA transcribed from
the L strand of the mtDNA.
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